| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |